Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 2
Submit an article Journal homepage
768
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective

Elisabeth LuporsiINSERM, Centre d’Investigations Cliniques-9501, CHU Nancy and Nancy-Université Vandoeuvre-lès-NancyFrance
,
Lamine MahiVifor Pharma Neuilly-sur-SeineFranceCorrespondence[email protected]
,
Camille MorreJNBD-Développement ParisFrance
,
Jorge WernliVifor Pharma AG GlattbruggSwitzerland
,
Gérard de PouvourvilleESSEC Cergy-PontoiseFrance
&
Roland BugatInstitut Claudius Regaud ToulouseFrance
Pages 225-232 | Accepted 07 Nov 2011, Published online: 05 Dec 2011

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bernd Froessler, Alexandra M Rueger & Mark P Connolly. (2018) Assessing the costs and benefits of perioperative iron deficiency anemia management with ferric carboxymaltose in Germany. Risk Management and Healthcare Policy 11, pages 77-82.
Read now

Articles from other publishers (10)

Andrew B. Song, David J. Kuter & Hanny Al‐Samkari. (2020) Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. American Journal of Hematology 95:10, pages 1180-1186.
Crossref
Thomas Drabinski, Kai Zacharowski, Patrick Meybohm, Alexandra M. Rüger & Antonio Ramirez de Arellano. (2020) Estimating the Epidemiological and Economic Impact of Implementing Preoperative Anaemia Measures in the German Healthcare System: The Health Economic Footprint of Patient Blood Management. Advances in Therapy 37:8, pages 3515-3536.
Crossref
Ashraf I. Mikhail, Staffan Schön, Sylvia Simon, Christopher Brown, Jörgen B. A. Hegbrant, Gert Jensen, Jason Moore & Lennart D. I. Lundberg. (2019) A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO). BMC Nephrology 20:1.
Crossref
Flávio Augusto Naoum. (2016) Iron deficiency in cancer patients. Revista Brasileira de Hematologia e Hemoterapia 38:4, pages 325-330.
Crossref
Heinz Ludwig, Rayko Evstatiev, Gabriela Kornek, Matti Aapro, Thomas Bauernhofer, Veronika Buxhofer-Ausch, Michael Fridrik, Dietmar Geissler, Klaus Geissler, Heinz Gisslinger, Elisabeth Koller, Gerhard Kopetzky, Alois Lang, Holger Rumpold, Michael Steurer, Houman Kamali & Hartmut Link. (2015) Iron metabolism and iron supplementation in cancer patients. Wiener klinische Wochenschrift 127:23-24, pages 907-919.
Crossref
Jorge Eduardo Toblli & Federico Di Gennaro. (2015) Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status. PLOS ONE 10:4, pages e0125528.
Crossref
Olivia Kelada & Laure Marignol. (2014) Erythropoietin-stimulating agents and clinical outcomes in metastatic breast cancer patients with chemotherapy-induced anemia: a closed debate?. Tumor Biology 35:6, pages 5095-5100.
Crossref
Iain C. Macdougall, Andreas Bock, Fernando Carrera, Kai-Uwe Eckardt, Carlo Gaillard, David Van Wyck, Bernard Roubert, Timothy Cushway & Simon D. Roger. (2014) The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Nephrology Dialysis Transplantation 29:4, pages 843-850.
Crossref
Punnada Athibovonsuk, Tarinee Manchana & Nakarin Sirisabya. (2013) Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. Gynecologic Oncology 131:3, pages 679-682.
Crossref
Nicolas Janus, Florian Scotte, Jean-Baptiste Rey, Sabine Amet, Laurence Rouillon, Lorraine Zakin, Lamine Mahi, Gilbert Deray & Vincent Launay-Vacher. (2013) Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. Supportive Care in Cancer 21:10, pages 2743-2748.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.